✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

United Therapeutics Corp

Common Name
United Therapeutics
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,305
Ticker
UTHR
Exchange
NASDAQ/NGS
Description
United Therapeutics Corporation is a biotechnology company engaged in the development and commercialization of innovative pharmaceutical products. Primarily focusing on therapies to address unmet medi...

United Therapeutics's Financial Statements Preview

Below are the financial statements of United Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
1,697.2a
1,207.7a
Marketable investments
1,569.8a
1,786.4a
Accounts receivable, no allowance for 2024 and 2023
279.3a
278.9a
Inventories, net
157.9a
111.8a
Other current assets
169.7a
166.2a
Total current assets
3,873.9a
3,551a
Marketable investments
1,475.3a
1,909.8a
Goodwill and other intangible assets, net
111.9a
114.2a
Property, plant, and equipment, net
1,222.4a
1,045.4a
Deferred tax assets, net
458.4a
394.8a
Other non-current assets
222.1a
151.8a
Total assets
7,364a
7,167a
Liabilities and stockholders’ equity
Current liabilities
Accounts payable and accrued expenses
344.5a
298a
Line of credit (current)
300a
400a
Share tracking awards plan
11a
35.4a
Other current liabilities
82.6a
71a
Total current liabilities
738.1a
804.4a
Line of credit (non-current)
0a
300a
Other non-current liabilities
181.9a
77.8a
Total liabilities
920a
1,182.2a
Stockholders’ equity
Preferred stock
0a
0a
Common stock
0.8a
0.7a
Additional paid-in capital
2,698.9a
2,549a
Accumulated other comprehensive loss
-3.4a
-12.8a
Treasury stock
-3,474.5a
-2,579.2a
Retained earnings
7,222.2a
6,027.1a
Total stockholders’ equity
6,444a
5,984.8a
Total liabilities and stockholders’ equity
7,364a
7,167a
Limited Data Preview
You are viewing a limited preview of United Therapeutics’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind United Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore United Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. United Therapeutics's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?